Repro-Med Systems, Inc. (KRMD)
Stock Price:
$6.43 USD
0.04 (0.63%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $6.45 +0.02 (0.31%) Oct 21, 5:06 PM
Key Info
| Market Cap |
282.34M |
| Revenue (ttm) |
26.88M |
| Net Income (ttm) |
-55,054 |
| Shares Out |
43.91M |
| EPS (ttm) |
-0.01 |
| PE Ratio |
n/a |
| Forward PE |
49.75 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 21, 2020 |
| Last Price |
$6.43 |
| Previous Close |
$6.39 |
| Change ($) |
0.04 |
| Change (%) |
0.63% |
| Day's Open |
6.38 |
| Day's Range |
6.11 - 6.45 |
| Day's Volume |
262,742 |
| 52-Week Range |
6.11 - 12.23 |
More Stats
| Market Cap |
282.34M |
| Enterprise Value |
248.02M |
| Earnings Date (est) |
Dec 16, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
43.91M |
| Float |
39.43M |
| EPS (basic) |
-0.01 |
| EPS (diluted) |
-0.01 |
| FCF / Share |
0.10 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
1.42% |
| Payout Ratio |
n/a |
| Shares Short |
1.33M |
| Short Ratio |
4.33 |
| Short % of Float |
3.37% |
| Beta |
0.30 |
| PE Ratio |
n/a |
| Forward PE |
49.75 |
| P/FCF Ratio |
70.33 |
| PS Ratio |
10.50 |
| PB Ratio |
7.51 |
| Revenue |
26.88M |
| Operating Income |
215,662 |
| Net Income |
-55,054 |
| Free Cash Flow |
4.01M |
| Net Cash |
34.32M |
| Net Cash / Share |
0.78 |
| Gross Margin |
55.26% |
| Operating Margin |
0.80% |
| Profit Margin |
-0.20% |
| FCF Margin |
14.93% |
| ROA |
9.54% |
| ROE |
-0.23% |
| ROIC |
4.70% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
4 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$14.00*
(117.73% upside)
Low
13.0
Current: $6.43
High
16.0
Target: 14.00
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|
| Revenue | 23.16 | 17.35 | 12.29 | 12.25 | 11.24 | 8.70 | 7.76 | 6.39 | 4.92 | 3.77 |
| Revenue Growth | 33.47% | 41.16% | 0.38% | 8.92% | 29.27% | 12.04% | 21.49% | 29.87% | 30.35% | - |
| Gross Profit | 14.85 | 10.81 | 7.57 | 7.60 | 6.69 | 5.31 | 4.94 | 4.14 | 3.26 | 2.51 |
| Operating Income | 0.59 | 1.16 | -0.74 | 1.18 | 1.15 | 1.01 | 1.06 | 1.29 | 1.19 | 0.72 |
| Net Income | 0.56 | 0.91 | -0.53 | 0.78 | 0.75 | 0.70 | 0.73 | 0.82 | 0.70 | 0.89 |
| Shares Outstanding | 38.78 | 38.13 | 37.83 | 37.99 | 37.63 | 36.66 | 36.01 | 34.25 | 36.24 | 35.38 |
| Earnings Per Share | 0.01 | 0.02 | -0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| EPS Growth | -50% | - | - | 0% | 0% | 0% | 0% | 0% | 0% | - |
| Operating Cash Flow | 0.32 | 1.48 | -0.33 | 1.91 | 0.83 | 0.95 | 0.78 | 0.56 | 1.03 | 0.38 |
| Capital Expenditures | 0.02 | -0.29 | -0.20 | -0.11 | -0.59 | -0.19 | -0.56 | -0.24 | -0.20 | -0.05 |
| Free Cash Flow | 0.34 | 1.19 | -0.53 | 1.81 | 0.23 | 0.77 | 0.22 | 0.32 | 0.83 | 0.33 |
| Cash & Equivalents | 5.87 | 5.26 | - | 4.46 | 2.82 | 2.49 | 2.19 | 2.01 | 1.47 | 0.81 |
| Total Debt | 0.38 | - | - | - | - | - | 0.44 | 0.48 | 0.52 | 0.69 |
| Net Cash / Debt | 5.49 | 5.26 | - | 4.46 | 2.82 | 2.49 | 1.75 | 1.53 | 0.95 | 0.12 |
| Assets | 13.88 | 10.55 | - | 8.39 | 7.28 | 6.21 | 5.59 | 4.81 | 3.43 | 2.99 |
| Liabilities | 2.65 | 1.58 | - | 1.28 | 1.01 | 1.02 | 1.24 | 1.25 | 0.95 | 1.30 |
| Book Value | 11.24 | 8.96 | - | 7.12 | 6.27 | 5.19 | 4.36 | 3.55 | 2.48 | 1.69 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Repro-Med Systems, Inc. |
| Country |
United States |
| Employees |
71 |
| CEO |
Donald B. Pettigrew |
Stock Information
| Ticker Symbol |
KRMD |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
NASDAQ: KRMD |
Description
Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.